about
Rapid metagenomic identification of viral pathogens in clinical samples by real-time nanopore sequencing analysis.Rapid metagenomic identification of viral pathogens in clinical samples by real-time nanopore sequencing analysisDevelopment and persistence of West Nile virus-specific immunoglobulin M (IgM), IgA, and IgG in viremic blood donors.Risk factors for retrovirus and hepatitis virus infections in accepted blood donors.Utilization of follow-up specimens from viremic blood donors to assess the value of west nile virus immunoglobulin G avidity as an indicator of recent infectionHigh levels of subgenomic HCV plasma RNA in immunosilent infectionsGenetic Variability of West Nile Virus in US Blood Donors, 2002–2005Genetic Variation in OAS1 Is a Risk Factor for Initial Infection with West Nile Virus in ManXenotropic murine leukemia virus-related virus (XMRV) and blood transfusion: report of the AABB interorganizational XMRV task forceGenetic Variability of West Nile Virus in U.S. Blood Donors from the 2012 Epidemic SeasonTransfusion-Transmitted InfectionsGenetic analysis of West Nile virus isolates from an outbreak in Idaho, United States, 2006-2007Pilot studies for development of an HIV subtype panel for surveillance of global diversity.West Nile virus infections projected from blood donor screening data, United States, 2003West Nile virus adheres to human red blood cells in whole blood.Seroconverting blood donors as a resource for characterising and optimising recent infection testing algorithms for incidence estimationCharacterization of immune responses to capsid protein p24 of human immunodeficiency virus type 1 and implications for detection.CCR5 deficiency is a risk factor for early clinical manifestations of West Nile virus infection but not for viral transmissionWest Nile fever characteristics among viremic persons identified through blood donor screening.Evolutionary dynamics of West Nile virus in the United States, 1999-2011: phylogeny, selection pressure and evolutionary time-scale analysis.Emerging infectious disease agents and their potential threat to transfusion safety.Genetic diversity of recently acquired and prevalent HIV, hepatitis B virus, and hepatitis C virus infections in US blood donorsSensitive detection assays for influenza RNA do not reveal viremia in US blood donorsProbability of viremia with HBV, HCV, HIV, and HTLV among tissue donors in the United States.Genomic Assays for Identification of Chikungunya Virus in Blood Donors, Puerto Rico, 2014.Distribution of Dengue Virus Types 1 and 4 in Blood Components from Infected Blood Donors from Puerto RicoProtecting the blood supply from emerging pathogens: the role of pathogen inactivation.Phylogenetic analysis of dengue virus types 1 and 4 circulating in Puerto Rico and Key West, Florida, during 2010 epidemicsUnifying the spatial epidemiology and molecular evolution of emerging epidemicsSerologic survey for exposure following fatal Balamuthia mandrillaris infectionLower-sensitivity and avidity modifications of the vitros anti-HIV 1+2 assay for detection of recent HIV infections and incidence estimation.Sensitivity of hepatitis C virus core antigen and antibody combination assays in a global panel of window period samplesEmerging infectious diseases that threaten the blood supply.Current risks of transfusion-transmitted agents: a review.Emerging infectious agents and the nation's blood supply: responding to potential threats in the 21st centuryEvidence for persistent low-level viremia in individuals who control human immunodeficiency virus in the absence of antiretroviral therapy.Chagas disease and the US blood supply.Transfusion-transmitted infectious diseases.A Comparative Study of Assay Performance of Commercial Hepatitis E Virus Enzyme-Linked Immunosorbent Assay Kits in Australian Blood Donor Samples.Antibody levels correlate with detection of Trypanosoma cruzi DNA by sensitive polymerase chain reaction assays in seropositive blood donors and possible resolution of infection over time.
P50
Q23047571-82519D66-90A0-4B6E-BE5B-9EB0F9F7A99BQ24286923-943558BF-E856-4BAB-A688-460791CB9460Q24570065-2CB22491-F9C2-4629-A90B-47AB3593AC57Q27346471-0F7567A8-E068-40E7-9638-4DFB69576F88Q27472109-690D481C-4204-47DC-B5E0-31AE5736C748Q27481224-54FFD528-23C1-4E3E-B8BE-ACAC723D6310Q27487086-725D54BD-00FF-438A-B431-4265E899E5E8Q27487937-DCC2D008-1F17-497F-856C-CE48889692B4Q28303254-9E17CBF6-E64E-42AD-93B7-26FC612C5479Q28552101-3E220BA4-3DC0-49E0-9885-6E4D135BFC19Q29571219-058884DC-E10C-45A8-B2DD-8B5C023E6CB0Q30448143-64B1510A-EA68-4985-AF69-631A03D2206BQ30514155-81C9C7B2-93A6-4F12-808E-C1E757F2D6E6Q31041026-F2EB89E2-9664-4737-BD64-2EFBE2AED891Q33288216-78009C21-5480-499D-BC3D-D305EDE8E700Q33939067-BEB6ACA7-E983-4AEE-BAFD-29FA1A03273AQ34044972-4EFE52DA-CAD2-4811-AACD-99D46BA553DCQ34108023-2714DF1A-37B1-43E9-B7EC-0D76F84D3154Q34623850-676C8D8A-228E-4F8E-9194-924042F5FD91Q34759105-06EEA533-F23D-46EF-B5CC-9669AE2A27A6Q34997865-491CC8F0-1574-42B4-B759-80B0F8AE9441Q35765985-CC121929-2D0E-4703-8615-4C9523873791Q35765991-828FE69A-0946-4CF5-ABBD-15E0B836C977Q35866205-CA614BFD-F680-4D20-98E0-C4E999B281E1Q35897107-60AB915A-E38C-494D-B43F-8D1C6E946C55Q35922064-BB12B87D-1B32-4D39-B8D8-AED0CE3BB572Q36106339-8428A4CB-462A-4926-BA4C-417E04A6EFEFQ36213316-8DAA05CC-1425-4E7A-849C-A66430265E76Q36236242-714B4B19-7BDF-40B7-A9B5-5C2AEF6D877EQ36376341-E28D0999-43AF-4D67-8697-6A3B4F1A1D91Q36414171-304E2F52-547D-48B5-801E-17DB9EF17467Q36554189-7129ACD4-3611-49C5-9CD8-E9B150EC4AD5Q36697213-D1B39922-FBF1-4441-AFEB-89CDEBEE5554Q36815106-97AC1F2F-C98A-4560-A382-588C8ADDFCD9Q36817997-21C8BC37-F2CA-411F-8B5E-0F017F8A3471Q37033224-98DF6D1D-3D3B-4663-9D9E-83AC0E424C78Q37251603-BC4A674A-B2AF-46A2-88AB-13601081A78CQ37397408-17CDD194-1056-4FCD-A908-ED0F6F995B6CQ37424582-1F0EC26F-0B9C-4DEF-83D5-1CB4F87B41BDQ37613699-DB4B120F-2A07-413E-92A0-0D719387DF7C
P50
name
Susan L Stramer
@ast
Susan L Stramer
@en
Susan L Stramer
@nl
type
label
Susan L Stramer
@ast
Susan L Stramer
@en
Susan L Stramer
@nl
prefLabel
Susan L Stramer
@ast
Susan L Stramer
@en
Susan L Stramer
@nl